Aclaris Therapeutics News, Aclaris Therapeutics Quote, ACRS Quote

Aclaris Therapeutics (NQ:ACRS) Delayed: 6.04 +0.02 (0.33%)

Prev. Close

$6.02

Today 6M 1Y 5Y

Open

$6.09

52 Wk High

$33.88

52 Wk Low

$14.12

Day High

$6.24

Day Low

$6.02

P/E

N/A

EPS

$0.00

Volume

147,503

Friends, Peers and Foes (?): NBI (more...)

ALERTS | RSS

Sep 1, 2026 06:20 AM Canaccord Starts Aclaris Therapeutis (ACRS) at Buy
Aug 31, 2026 08:52 AM Piper Sandler on Aclaris Therapeutis (ACRS): 'Efficacy Differentiation Could Drive Share Re-Rate'
Aug 14, 2026 04:44 PM Form SCHEDULE 13G/A Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 6, 2026 05:15 PM Form 8-K Aclaris Therapeutics, For: Aug 06
Aug 6, 2026 05:08 PM Form S-3ASR Aclaris Therapeutics,
Aug 6, 2026 04:37 PM Form 10-Q Aclaris Therapeutics, For: Jun 30
Aug 6, 2026 04:36 PM FDA grants fast track status to Aclaris drug for lichen planus
Aug 6, 2026 04:35 PM Aclaris Therapeutics Receives Fast Track Designation for Modzatinib (ATI-2138) for Moderate to Severe Lichen Planus (LP)
Aug 6, 2026 07:15 AM Form 8-K Aclaris Therapeutics, For: Aug 06
Aug 6, 2026 07:05 AM Aclaris Therapeutics (ACRS) Tops Q2 EPS by 1c

Entities mentioned with ACRS

View All Entities